A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
Clinical trial NCT05217446 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05217446
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-11
- Primary completion
- 2026-06-19
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.